Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30163% above fair value
$39.20−0.25 (-0.63%)
Close on Nov 19, 2026Market cap $1.83BP/E –Yield –
Septerna shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Septerna's shares outstanding was 47M at Sep 30, 2026. For fiscal 2025 it was 44M, up 347.5% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 44M | +347.5% |
| FY2024 | Dec 31, 2024 | 10M | +354.3% |
| FY2023 | Dec 31, 2023 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 47M | +2.9% |
| Q2 FY2026 | Jun 30, 2026 | 45M | +2.0% |
| Q1 FY2026 | Mar 31, 2026 | 45M | +1.9% |
| Q4 FY2025 | Dec 31, 2025 | 45M | +1724.4% |
| Q3 FY2025 | Sep 30, 2025 | 46M | +1850.8% |
| Q2 FY2025 | Jun 30, 2025 | 44M | +1878.5% |
| Q1 FY2025 | Mar 31, 2025 | 44M | +1307.2% |
| Q3 FY2024 | Sep 30, 2024 | 2M | +21.7% |
| Q2 FY2024 | Jun 30, 2024 | 2M | – |
| Q1 FY2024 | Mar 31, 2024 | 2M | – |
| Q4 FY2023 | Dec 31, 2023 | 3M | – |
| Q3 FY2023 | Sep 30, 2023 | 2M | – |
See a number that looks wrong?